amikacin has been researched along with Canine Diseases in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Arnold, RD; Bateman, FL; Brown, AR; Griffies, JD; Jasper, SL; Klinczar, AM | 1 |
| Borjesson, DL; Vasilatis, DM; Walker, NJ | 1 |
| Batzias, GC; Delis, GA; Koutsoviti-Papadopoulou, M; Siarkou, VI; Vingopoulou, EI | 1 |
| Cross, AR; Frederick, SW; Lee, SJ | 1 |
| Cohen, ND; Gold, RM; Lawhon, SD | 1 |
| Cooke, K; Torres, AR | 1 |
| Fukui, E; Hasegawa, A; Okada, Y; Usui, R | 1 |
| Anders, BB; Reed, TP; Ruth, JD; Thomas, LA; Weeren, FR | 1 |
| Gibson, TW; Nazarali, A; Rousseau, J; Singh, A; Walker, M; Weese, JS | 1 |
| Kontos, V; Papadogiannakis, E; Perimeni, D; Vatopoulos, A; Velonakis, E | 1 |
| Gibbs, PS; Kemp, DT; Sparks, TA; Wooley, RE | 1 |
| Boothe, DM; Boothe, HW; Howe, LM | 1 |
| Burke, TJ; Campbell, KL; Kakoma, I; Kim, CH; Koo, HY; McKiernan, BC; Oluoch, AO; Siegel, AM; Weisiger, RM | 1 |
| Lees, GE; Rogers, KS; Simpson, RB | 1 |
1 trial(s) available for amikacin and Canine Diseases
| Article | Year |
|---|---|
A novel dextran polymer hydrogel local antimicrobial therapy in dogs: A pilot study.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Clindamycin; Dextrans; Dog Diseases; Dogs; Female; Hydrogels; Male; Pilot Projects; Surgical Wound Infection | 2016 |
13 other study(ies) available for amikacin and Canine Diseases
| Article | Year |
|---|---|
Determination of amikacin stability at 1% and 3% concentrations in four topical solutions over a 56-day period.
Topics: Amikacin; Animals; Chromatography, High Pressure Liquid; Dog Diseases; Dogs; Drug Stability; Otitis Externa; Solutions | 2022 |
Amikacin disaggregates platelet clumps in EDTA blood samples from cats and dogs when added postcollection.
Topics: Amikacin; Animals; Cat Diseases; Cats; Dog Diseases; Dogs; Edetic Acid; Fibrinogen; Platelet Count; Prospective Studies; Thrombocytopenia | 2023 |
Pharmacodynamic interactions of amikacin with selected β-lactams and fluoroquinolones against canine Escherichia coli isolates.
Topics: Amikacin; Animals; Anti-Bacterial Agents; beta-Lactams; Dog Diseases; Dogs; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Microbial Sensitivity Tests | 2018 |
Use of an amikacin-infused collagen sponge concurrent with implant removal for treatment of tibial plateau leveling osteotomy surgical site infection in 31 cases.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Bandages; Collagen; Device Removal; Dog Diseases; Dogs; Female; Male; Osteotomy; Postoperative Period; Retrospective Studies; Surgical Wound Infection; Tibia; Treatment Outcome | 2019 |
Amikacin resistance in Staphylococcus pseudintermedius isolated from dogs.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Dog Diseases; Dogs; Drug Resistance, Bacterial; Genes, Bacterial; Genotype; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus | 2014 |
Intravesical instillation of amikacin for treatment of a lower urinary tract infection caused by Pseudomonas aeruginosa in a dog.
Topics: Administration, Intravesical; Amikacin; Animals; Anti-Bacterial Agents; Dog Diseases; Dogs; Drug Resistance, Multiple, Bacterial; Female; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Urinary Tract Infections | 2014 |
A canine case of otitis media examined and cured using a video otoscope.
Topics: Adenoma; Amikacin; Animals; Anti-Bacterial Agents; Dog Diseases; Dogs; Ear Neoplasms; Laser Therapy; Male; Otitis Media; Pseudomonas aeruginosa; Pseudomonas Infections; Video Recording | 2015 |
Evaluation of the Impact of Methicillin-Resistant Staphylococcus pseudintermedius Biofilm Formation on Antimicrobial Susceptibility.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Biofilms; Canada; Cefazolin; Dog Diseases; Dogs; Enrofloxacin; Fluoroquinolones; Gentamicins; Methicillin Resistance; Plankton; Staphylococcal Infections; Staphylococcus; United States | 2016 |
Providencia stuartii infection in a dog with severe skin ulceration and cellulitis.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Cellulitis; Diagnosis, Differential; Dog Diseases; Dogs; Enterobacteriaceae Infections; Female; Providencia; Skin Ulcer; Treatment Outcome | 2007 |
Antimicrobial effect of combinations of EDTA-Tris and amikacin or neomycin on the microorganisms associated with otitis externa in dogs.
Topics: Amikacin; Animals; Dog Diseases; Dogs; Drug Interactions; Drug Synergism; Edetic Acid; Escherichia coli; Microbial Sensitivity Tests; Neomycin; Otitis Externa; Proteus mirabilis; Pseudomonas aeruginosa; Staphylococcus; Tromethamine | 1994 |
Detection of portal and systemic bacteremia in dogs with severe induced hepatic disease and multiple portosystemic shunts.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Bacteremia; Dog Diseases; Dogs; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Hypertension, Portal; Imipenem; Liver Cirrhosis, Experimental; Male; Portal System; Portography; Pseudomonas aeruginosa; Quinolones; Random Allocation; Thienamycins | 1999 |
Nonenteric Escherichia coli isolates from dogs: 674 cases (1990-1998).
Topics: Amikacin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Dog Diseases; Dogs; Drug Resistance, Microbial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Gentamicins; Infections; Male; Microbial Sensitivity Tests; Norfloxacin; Quinolones; Respiratory System; Retrospective Studies; Skin; Urine | 2001 |
Effects of single-dose and three-day trimethoprim-sulfadiazine and amikacin treatment of induced Escherichia coli urinary tract infections in dogs.
Topics: Amikacin; Animals; Anti-Infective Agents, Urinary; Bacteriuria; Dog Diseases; Dogs; Drug Administration Schedule; Drug Combinations; Escherichia coli Infections; Female; Male; Random Allocation; Sulfadiazine; Trimethoprim; Urinary Tract Infections | 1988 |